Canada approves Moderna’s RSV vaccine for those age 60 and older, company says

A vaccine box and syringe for mRESVIA.

Moderna said on Friday Canada’s health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years and older, making it the country’s first authorized mRNA-based shot for the condition.

Full Article

via YO SEO TOOLS

Avatar

By Icanada

Related Post

One thought on “Canada approves Moderna’s RSV vaccine for those age 60 and older, company says”

Leave a Reply

Your email address will not be published. Required fields are marked *